Name: Renee Gaeta
New title: Chief financial officer, Shockwave Medical
Previous title: Chief financial officer, Eko Health
Renee Gaeta is taking over as CFO of cardiovascular disease device developer Shockwave Medical, the company said Monday.
Gaeta left Eko Health, the digital stethoscope developer she joined as CFO in 2021, this month and will take up the same position at Shockwave next week, according to a filing with the U.S. Securities and Exchange Commission. While Eko is privately held, Gaeta has experience at public companies from her four years at Establishment Labs Holdings, the medtech company she helped to hold an initial public offering in 2018.
That experience persuaded Shockwave, a company with a market capitalization of around $8 billion, to make Gaeta its next CFO. In a statement, Shockwave CEO Doug Godshall called Gaeta a “highly skilled and accomplished executive with a proven track record in the medical device and healthcare industries.”
Gaeta will receive an annual base salary of $500,000.
The appointment comes as Shockwave works to penetrate what it sees as a $14.5 billion opportunity in calcified cardiovascular disease, refractory angina and other smaller indications.
Shockwave currently has its core coronary intravascular lithotripsy opportunity to itself. Abbott acquired rival technology in its $890 million takeover of Cardiovascular Systems, but Morgan Stanley analysts wrote in July that it is unlikely to bring a product to market before 2026.
Boston Scientific reportedly looked into buying Shockwave last year.
Gaeta is filling the vacancy created by Dan Puckett, who Shockwave announced in September would retire in the first quarter. Puckett resigned Monday but will continue to support the company as a consultant as part of an agreement that entitles him to $20,000 a month from Feb. 5 to Oct. 4, followed by $10,000 a month from Oct. 5 through Feb. 4, 2025.